Metabolic-Fit / 100
Invyncible review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
The catalog advertises semaglutide from $145 and tirzepatide from $170, with supply duration unconfirmed. Catalog offers and linked product prices conflict, so confirm formulation, supply duration and renewal price.
- Confirm HSA / FSA coverage
- Public information reviewed
- Confirm your total cost
Invyncible at a glance
- Semaglutide
- From $145 advertised program price (duration unconfirmed)
- Tirzepatide
- From $170 advertised program price (duration unconfirmed)
- Coverage
- Not publicly disclosed; confirmed during intake
- Brand-name
- Yes
How we scored Invyncible
Every factor comes from Invyncible's own published pricing, disclosures and oversight, and the six combine into the 45/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
The catalog advertises semaglutide from $145 and tirzepatide from $170, with supply duration unconfirmed. Catalog offers and linked product prices conflict, so confirm formulation, supply duration and renewal price.
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $145 | Standard Formula InjectionsFrom $145 advertised program price (duration unconfirmed). Catalog offers and linked product prices conflict, so confirm formulation, supply duration and renewal price. |
| Compounded tirzepatide | $170 | Standard Formula InjectionsFrom $170 advertised program price (duration unconfirmed). Catalog offers and linked product prices conflict, so confirm formulation, supply duration and renewal price. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Invyncible's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- The catalog advertises semaglutide from $145 and tirzepatide from $170, with supply duration unconfirmed.
- Discloses its corporate parent and a physical address — real accountability, not just a trade name
- LegitScript-verified
- Sells both compounded programs and FDA-approved brand Wegovy/Zepbound on one account
The caveats
- Catalog offers and linked product prices conflict, so confirm formulation, supply duration and renewal price.
- No state-availability list published — you find out if it reaches you during intake
- Nothing on the site addresses pregnancy, breastfeeding, or postpartum timing specifically
The catalog is easier to browse than to budget from
Invyncible puts both semaglutide and tirzepatide programs in a public catalog, rather than making every visitor complete an assessment just to discover a number. Its advertised floors are $145 for semaglutide and $170 for tirzepatide. The limitation is the missing supply duration: neither figure should be treated as an established monthly medication budget.
The catalog and linked product pages also show conflicting prices. That makes the selected product more important than the cheapest number on the category page. Before proceeding, obtain one quote naming the formulation, quantity, period covered and renewal charge. A low catalog floor is useful for finding a possible option; it does not settle what the prescription will cost over continuing treatment.
Formulation choices need their own quotes
The tirzepatide catalog includes several formulations, including products described with B vitamins or glycine. These are distinct selections, and a price attached to one should not silently become the price for every other version. Ask the clinician which formulation is proposed and why, then compare its written terms with the corresponding product page.
Invyncible also describes access to brand Wegovy and Zepbound alongside compounded programs. That choice may matter to someone who wants a named approved product, but the compounded program floor is not a brand-drug quote. Keep the product identity and payment arrangement together throughout the assessment; switching between them changes the question the advertised price was answering.
There is some corporate accountability
The company discloses a corporate parent and a physical address. Those details provide more information about who operates the service than a trade name and contact form alone. They are useful starting points for resolving a billing issue or determining which company will hold the patient relationship, without proving the quality of every clinical decision.
Invyncible displays a LegitScript seal. Treat that as a certification claim to check against the linked certification record, rather than a substitute for identifying the prescriber and dispensing pharmacy. The useful chain is specific: the company taking payment, the clinician making the treatment decision and the pharmacy preparing or dispensing the selected medication.
Coverage and ongoing care still need clarification
There is no public state-by-state availability list in its published information. Someone considering Invyncible should establish that both the clinical service and the selected pharmacy can serve the intended address before treating a catalog product as available. A nationwide-looking website does not answer that question by itself.
Its public FAQ has described cancellation without a long-term commitment. That is worth distinguishing from a refund after a prescription has been prepared or shipped. Confirm the next renewal date, the cancellation method and the point at which an order can no longer be stopped. Also establish how to reach the care team between orders and how changes to the prescription affect billing.
Who should investigate further
Its public information does not explain pregnancy, breastfeeding or postpartum timing specifically. A broad selection of weight-loss products therefore should not be read as a dedicated maternal-care program. Bring those circumstances to the actual treating clinician rather than assuming that the catalog or certification seal addresses them.
Invyncible is most relevant to a reader who values several product routes and wants to compare them before choosing a service. Its corporate disclosure is helpful, but the unresolved catalog-to-product pricing and supply period are consequential. A written prescription-specific quote and confirmation of state access are the practical next steps before relying on either advertised floor.
The bottom line for mothers
Best for: A mother who wants the option to start compounded and later move to an FDA-approved brand pen without switching providers, and who values knowing the company's actual name and address.
Alternatives to Invyncible
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit ShedRx76
Metabolic-Fit / 100
The widest menu on our list — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, prices published for every plan length, and cancellation terms among the most restrictive we have read.
- Visit MEDGm42
Metabolic-Fit / 100
Four named pharmacies, a named prescribing partner and brand-name Wegovy, Zepbound and Ozempic alongside the compounded line — that is a fuller disclosure than most providers we review manage. Compounded GLP-1 injections start at $179 a month and daily dissolvable tablets at $249, and the price attaches to the form rather than the molecule: the product page never says whether you are getting semaglutide or tirzepatide, and the terms confirm both are in scope. Two things deserve a mother's attention before she enrolls. The brand products are priced as a membership plus an undisclosed medication cost, and that membership is quoted at two different figures on one page, $99 beside Zepbound and Wegovy and $171 beside Ozempic. And the terms state that if a provider decides a different molecule suits you better, staying enrolled is itself your consent to the switch and the charges continue. It also discloses, unusually plainly, that people shown in its advertising may be actors or artificial intelligence rather than clinicians.
Providers like Invyncible
Keep comparing Invyncible
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
Invyncible, answered
- How much does Invyncible cost?
- Invyncible does not establish a comparable recurring monthly medication rate. Published pricing: From $145 advertised program price (duration unconfirmed) for semaglutide; From $170 advertised program price (duration unconfirmed) for tirzepatide. Ask for the complete charge, supply period and renewal terms before committing.
- Is Invyncible safe to use while breastfeeding?
- None of these drugs is established as safe in pregnancy, so stopping before you try to conceive is the usual plan. If you are nursing, the Wegovy injection, Ozempic, Zepbound and Mounjaro labels say there is little or no data on the drug in breast milk, and they leave it to you and your clinician to weigh the benefits of breastfeeding against your need for treatment. Compounded versions carry no label of their own; ask the prescriber directly how they handle nursing patients. Invyncible is not an exception to any of that — settle the timing with your own clinician.
- Does Invyncible offer both semaglutide and tirzepatide?
- Yes — Invyncible offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- How does Invyncible score for mothers?
- Invyncible scores 45/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.
Pricing, states and verification reflect Invyncible's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.